Tags

Type your tag names separated by a space and hit enter

Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Pediatr Blood Cancer. 2019 10; 66(10):e27934.PB

Abstract

BACKGROUND

Our objective was to investigate the combined and differential effects of alpha-thalassemia -3.7 kb deletion and HbF-promoting quantitative trait loci (HbF-QTL) in Senegalese hydroxyurea (HU)-free children and young adults with sickle cell anemia (SCA).

PROCEDURE

Steady-state biological parameters and vaso-occlusive crises (VOC) requiring emergency admission were recorded over a 2-year period in 301 children with SCA. The age of the first hospitalized VOC was also recorded. These data were correlated with the alpha-globin and HbF-QTL genotypes. For the latter, three different genetic loci were studied (XmnI, rs7482144; BCL11A, rs1427407; and the HBS1L-MYB region, rs28384513) and a composite score was calculated, ranging from zero (none of these three polymorphisms) to six (all three polymorphisms at the homozygous state).

RESULTS

A positive clinical impact of the HbF-QTL score on VOC rate, HbF, leucocytes, and C-reactive protein levels was observed only for patients without alpha-thalassemia deletion. Conversely, combination of homozygous -3.7 kb deletion with three to six HbF-QTL was associated with a higher VOC rate. The age of the first hospitalized VOC was delayed for patients with one or two alpha-thalassemia deletions and at least two HbF-QTL.

CONCLUSION

Alpha-thalassemia -3.7 kb deletion and HbF-QTL are modulating factors of SCA clinical severity that interact with each other. They should be studied and interpreted together and not separately, at least in HU-free children.

Authors+Show Affiliations

Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal. Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie vasculaire et du globule rouge", Université Claude Bernard Lyon 1, COMUE, Lyon, France. Centre Hospitalier National d'Enfants Albert Royer, Dakar, Sénégal.Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie vasculaire et du globule rouge", Université Claude Bernard Lyon 1, COMUE, Lyon, France. Laboratoire d'Excellence sur le globule rouge (Labex GR-Ex), Paris, France.Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal. Centre Hospitalier National d'Enfants Albert Royer, Dakar, Sénégal.Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie vasculaire et du globule rouge", Université Claude Bernard Lyon 1, COMUE, Lyon, France. UF "Biochimie des pathologies érythrocytaires", Laboratoire de Biochimie et Biologie moléculaire Grand-Est, Groupement hospitalier Est, Hospices Civils de Lyon, Bron, France.Centre Hospitalier National d'Enfants Albert Royer, Dakar, Sénégal. Service universitaire de Pédiatrie-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal.Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie vasculaire et du globule rouge", Université Claude Bernard Lyon 1, COMUE, Lyon, France. Laboratoire d'Excellence sur le globule rouge (Labex GR-Ex), Paris, France. Institut Universitaire de France, Paris, France.Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal.Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal.Service universitaire de Pédiatrie-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal. UFR des sciences de la santé - Université Gaston Berger, Saint-Louis, Sénégal.Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal.Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal.Laboratoire de Biochimie Pharmaceutique-FMPO, Université Cheikh Anta Diop, Dakar, Sénégal. Centre Hospitalier National d'Enfants Albert Royer, Dakar, Sénégal.Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe "Biologie vasculaire et du globule rouge", Université Claude Bernard Lyon 1, COMUE, Lyon, France. Laboratoire d'Excellence sur le globule rouge (Labex GR-Ex), Paris, France. UF "Biochimie des pathologies érythrocytaires", Laboratoire de Biochimie et Biologie moléculaire Grand-Est, Groupement hospitalier Est, Hospices Civils de Lyon, Bron, France.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31322815

Citation

Gueye Tall, Fatou, et al. "Combined and Differential Effects of Alpha-thalassemia and HbF-quantitative Trait Loci in Senegalese Hydroxyurea-free Children With Sickle Cell Anemia." Pediatric Blood & Cancer, vol. 66, no. 10, 2019, pp. e27934.
Gueye Tall F, Martin C, Ndour EHM, et al. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia. Pediatr Blood Cancer. 2019;66(10):e27934.
Gueye Tall, F., Martin, C., Ndour, E. H. M., Renoux, C., Ly, I. D., Connes, P., Gueye, P. M., Diallo, R. N., Diagne, I., Diop, P. A., Cissé, A., Lopez Sall, P., & Joly, P. (2019). Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia. Pediatric Blood & Cancer, 66(10), e27934. https://doi.org/10.1002/pbc.27934
Gueye Tall F, et al. Combined and Differential Effects of Alpha-thalassemia and HbF-quantitative Trait Loci in Senegalese Hydroxyurea-free Children With Sickle Cell Anemia. Pediatr Blood Cancer. 2019;66(10):e27934. PubMed PMID: 31322815.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia. AU - Gueye Tall,Fatou, AU - Martin,Cyril, AU - Ndour,El Hadji Malick, AU - Renoux,Céline, AU - Ly,Indou Déme, AU - Connes,Philippe, AU - Gueye,Papa Madieye, AU - Diallo,Rokhaya Ndiaye, AU - Diagne,Ibrahima, AU - Diop,Pape Amadou, AU - Cissé,Aynina, AU - Lopez Sall,Philomène, AU - Joly,Philippe, Y1 - 2019/07/19/ PY - 2019/03/15/received PY - 2019/06/16/revised PY - 2019/07/07/accepted PY - 2019/7/20/pubmed PY - 2020/2/6/medline PY - 2019/7/20/entrez KW - G6PD deficiency KW - HbF QTL KW - Senegal haplotype KW - alpha-thalassemia KW - genetic modifiers KW - sickle cell anemia SP - e27934 EP - e27934 JF - Pediatric blood & cancer JO - Pediatr Blood Cancer VL - 66 IS - 10 N2 - BACKGROUND: Our objective was to investigate the combined and differential effects of alpha-thalassemia -3.7 kb deletion and HbF-promoting quantitative trait loci (HbF-QTL) in Senegalese hydroxyurea (HU)-free children and young adults with sickle cell anemia (SCA). PROCEDURE: Steady-state biological parameters and vaso-occlusive crises (VOC) requiring emergency admission were recorded over a 2-year period in 301 children with SCA. The age of the first hospitalized VOC was also recorded. These data were correlated with the alpha-globin and HbF-QTL genotypes. For the latter, three different genetic loci were studied (XmnI, rs7482144; BCL11A, rs1427407; and the HBS1L-MYB region, rs28384513) and a composite score was calculated, ranging from zero (none of these three polymorphisms) to six (all three polymorphisms at the homozygous state). RESULTS: A positive clinical impact of the HbF-QTL score on VOC rate, HbF, leucocytes, and C-reactive protein levels was observed only for patients without alpha-thalassemia deletion. Conversely, combination of homozygous -3.7 kb deletion with three to six HbF-QTL was associated with a higher VOC rate. The age of the first hospitalized VOC was delayed for patients with one or two alpha-thalassemia deletions and at least two HbF-QTL. CONCLUSION: Alpha-thalassemia -3.7 kb deletion and HbF-QTL are modulating factors of SCA clinical severity that interact with each other. They should be studied and interpreted together and not separately, at least in HU-free children. SN - 1545-5017 UR - https://www.unboundmedicine.com/medline/citation/31322815/Combined_and_differential_effects_of_alpha_thalassemia_and_HbF_quantitative_trait_loci_in_Senegalese_hydroxyurea_free_children_with_sickle_cell_anemia_ DB - PRIME DP - Unbound Medicine ER -